COMPANY PROFILE · UPDATED 01 AUG 2026

REVOLUTION Medicines

Revolution Medicines, Inc. operates as an oncology company. The Company discovers novel targeted therapies to inhibit elusive frontier targets within notorious growth and survival pathways. Revolution Medicines serves customers worldwide.

revolutionmedicines.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2014
Headcount: 337
Open roles: 263
Last raised: Post Ipo Equity · Sign in to view

TECH STACK

How REVOLUTION Medicines builds

Extracted from REVOLUTION Medicines’s job postings we’ve tracked

Other Software & Platforms

Microsoft Office×32 Microsoft Project×18 NetSuite×13 Workday×10 Veeva Vault×8

Cloud Platforms

Google Cloud×52 Microsoft Azure×5

CRM & Sales Tools

Veeva×18 Veeva CRM×5 Salesforce×4

Collaboration & Productivity

Smartsheet×25

Analytics & BI

Microsoft Excel×8 Microsoft Power BI×8 Tableau×5

Frameworks & Libraries

NumPy×7 pandas×7 CMS×6

AI & Machine Learning

PyTorch×7 TensorFlow×7

Programming Languages

Python×8

LEADERSHIP

Founders & key people

OPEN ROLES

Hiring at REVOLUTION Medicines

View all 263 open roles →

FUNDING

Capital raised

Total raised

$4,254,400,102

Investors

Boxer CapitalBvf PartnersCasdin CapitalCormorant CapitalDeerfield Capital ManagementFidelity InvestmentsNextech InvestRoyalty PharmaSchroder AdveqThe Column GroupThird Rock VenturesVivo Capital

Funding rounds

Post Ipo Equity
$1.5BApr 15, 2026
Post Ipo Debt
$500MApr 15, 2026
Post Ipo Debt
Royalty Pharma
$250MJun 23, 2025
Post Ipo Equity
$750MDec 1, 2024
Post Ipo Equity
$323.6MMar 1, 2023
Post Ipo Equity
$264.5MJul 18, 2022
Post Ipo Equity
$260.9MFeb 2, 2021
Post Ipo Equity
$179.4MJul 7, 2020
IPO
UndisclosedJan 1, 2020
Series C
Boxer Capital, The Column Group, Fidelity Investments, Third Rock Ventures, Deerfield Capital Management, Bvf Partners, Vivo Capital, Casdin Capital, Cormorant Capital, Schroder Adveq, Nextech Invest
$100MJul 8, 2019
Series B
Nextech Invest, Casdin Capital, The Column Group, Third Rock Ventures, Schroder Adveq
$56MApr 23, 2018
Series A
The Column Group, Third Rock Ventures
$25MDec 19, 2016
Series A
Third Rock Ventures
$45MFeb 3, 2015

Funding data via Diffbot

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery

Industries

Medical Organizations Health Care Companies Biotechnology Companies

Tech Stack

Php Python Java Microsoft Azure

LOCATIONS

Where they work

REVOLUTION Medicines Headquarters Location

700 Saginaw Dr, Redwood City, CA, 94063-4752

Loading map…